Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: Insights into Parkinson's disease

Files

Banks_Chaperone_proteins_as_ameliorators_of_α-synuclein-induced_synaptic_pathologies_insights_into_Parkinson’s_disease.pdf (1.02 MB)

Date

2021-06

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Wolters Kluwer Medknow Publications

Abstract

Neurodegenerative disorders, such as Parkinson’s disease (PD) and other synucleinopathies, impact the lives of millions of patients and their caregivers. Synucleinopathies include PD, dementia with Lewy Bodies (DLB), multiple system atrophy, and several Alzheimer’s Disease variants. They are clinically characterized by intracellular inclusions called Lewy Bodies, which are rich in atypical aggregates of the protein α-synuclein. While dopaminergic neurons in the substantia nigra are particularly susceptible to α-synuclein-induced aggregation and neurodegeneration, glutamatergic neurons in other brain regions (e.g. cortex) are also frequently affected in PD and other synucleinopathies (Schulz-Schaeffer 2010). Several point mutations in the α-synuclein gene (SNCA), as well as duplication/triplication of SNCA, are linked to familial Parkinson’s disease.

Description

Keywords

Parkinson's disease, Alpha-synuclein, Molecular chaperones

Citation

Banks, S. M. L., Medeiros, A. T., Sousa, R., Lafer, E. M., & Morgan, J. R. (2021). Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: Insights into Parkinson’s disease. Neural Regeneration Research, 16(6), 1198-1199. https://doi.org/10.4103/1673-5374.300431

URI

https://doi.org/10.4103/1673-5374.300431

DOI

Collections

Biology